Prevalence and risk factors for thromboembolism in women with sickle cell disease during pregnancy

Shreya Agarwal, M.D.
Nationwide Children’s Hospital
Columbus, OH, U.S.

Pregnancy in women with sickle cell disease (SCD) may further enhance the prothrombotic effect of SCD putting an individual at an even higher risk for thromboembolism. Agarwal, M.D., will present analysis of administrative claims data from the United States Centers for Medicare and Medicaid Service Analytic eXtract from 2006-2018 discussing the prevalence and risk factors for thromboembolism in pregnant women with sickle cell disease. The increased risk of thrombosis in pregnant women with sickle cell disease potentially qualifies them as candidates for thromboprophylaxis.